AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MacroGenics acquires Eliance, establishes partnership in immunotherapeutics with UT Southwestern.(Brief Article)
2002 JUL 10 - (NewsRx.com & NewsRx.net) -- MacroGenics, Inc., announced the acquisition of Eliance Biotechnology, Inc., a private vaccine discovery company located in Dallas, Texas, which was founded to exploit technology developed at The University of Texas Southwestern Medical Center at Dallas (UT Southwestern) Center for Biomedical Inventions (CBI).
The company and university also announced the formation of an alliance between MacroGenics and UT Southwestern to enhance discovery and development of immunotherapeutics to prevent and treat cancer and autoimmune and infectious diseases.
The agreements include: the establishment of a MacroGenics research site in Dallas for infectious disease target identification and development ...
- MacroGenics Acquires Eliance, Inc., and Establishes Partnership in...
- Press release article from: PR Newswire June 7, 2002 700+ words
...alliance between MacroGenics and UT Southwestern to enhance discovery...agreements with UT Southwestern, MacroGenics raised an additional...by the teams at UT Southwestern and Eliance will...existing assets at MacroGenics and position it...
- MacroGenics Acquires Eliance, Raises $12.6M In Financing.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...includes establishing a MacroGenics research site in Dallas...genetic immunization. MacroGenics is licensing a patent...research agreement with UT Southwestern in the field of immunobiology. MacroGenics is striving to "create...
- MACROGENICS ACQUIRES ELIANCE, RAISES $12.6M IN FINANCING.(Brief Article)
- Magazine article from: BIOWORLD Today Osborne, Randall June 7, 2002 700+ words
...includes establishing a MacroGenics research site in Dallas...genetic immunization. MacroGenics is licensing a patent...research agreement with UT Southwestern in the field of immunobiology. MacroGenics is striving to "create...
- Rockville, Md.-Based MacroGenics Acquires Dallas Biotech Firm.
- Newspaper article from: Knight Ridder/Tribune Business News June 8, 2002 700+ words
...merger of Eliance and MacroGenics sets a new standard...Dennis Stone of UT Southwestern, in a statement...the transaction, MacroGenics raised $12.6 million...Richardson, right by UT Southwestern," said H. Ronald...
- MacroGenics Acquires Raven Biotechnologies.
- Press release article from: PR Newswire July 17, 2008 700+ words
...in Cancer Stem Cell Biology Enhances MacroGenics' Oncology Capabilities and Complements...Md., July 17 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology...cell biology is highly complementary to MacroGenics' proprietary Fc-optimization and...
- MacroGenics Announces Grand Opening of New cGMP Manufacturing Facility in...
- Press release article from: PR Newswire October 19, 2005 700+ words
...Md., Oct. 19 /PRNewswire/ -- MacroGenics, Inc. today announced the grand opening...Edgerley also joined members of the MacroGenics senior management for the official ribbon...Scott Koenig, President and CEO of MacroGenics, Inc. commented on the new facility...
- MacroGenics Builds Senior Management Team by Adding CFO and VP of Clinical...
- Press release article from: PR Newswire June 17, 2005 700+ words
...Md., June 17 /PRNewswire/ -- MacroGenics, Inc. today announced the addition...Scott Koenig, President and CEO of MacroGenics, stated, "We could not be more pleased...scientific expertise are strong assets as MacroGenics enters clinic development and positions...
- MacroGenics Raises $25M in Series D-2 Financing.
- Press release article from: PR Newswire September 25, 2008 700+ words
...Md., Sept. 25 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology...Pacific Group Ventures and Ventures West. MacroGenics expects to use the proceeds from this...for general working capital purposes. MacroGenics' most advanced product candidate is...